Verv is creating the first-of-its-kind consumer-oriented, affordable, high-quality blood chemistry analyser.
Verv Technologies has raised $3.0M in total funding. The most recent round was Seed. The last funding was announced in July 2022.
Verv Technologies's investors include National Research Council of Canada Industrial Research Assistance Program, Randox, Northern Ontario Heritage Fund, The Sudbury Catalyst Fund.
Verv Technologies is headquartered in Sudbury, Canada.
Verv is creating the first-of-its-kind consumer-oriented, affordable, high-quality blood chemistry analyser.
Verv Technologies is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Verv Technologies — Funding & Investors." VCBacked, July 21, 2022, https://www.vcbacked.co/company/verv-technologies. Accessed August 13, 2026.
VCBacked. (2022). Verv Technologies — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/verv-technologies
{{cite web |title=Verv Technologies — Funding & Investors |url=https://www.vcbacked.co/company/verv-technologies |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated